Long-term survival of a child with homozygous protein C deficiency successfully treated with living donor liver transplantation

Pediatric Transplantation

Volumn 13, Issue 2, 2009, Pages 251-254

  Lee, Mee Jeong ^b,c   Kim, Kyung Mo ^b   Kim, Joon Sung ^b,d   Kim, Yoon Jeong ^b,e   Lee, Young Joo ^b   Ghim, Thad T ^a,b  

^a National Cancer Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Dankook University College of Medicine   (South Korea)

^d Ulsan University College of Medicine   (South Korea)

^e Ye In Pediatric Clinic   (South Korea)

Author keywords

Living donor liver transplantation; Neonatal purpura fulminans; Protein C deficiency

Indexed keywords

CORTICOSTEROID; CREATININE; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; TACROLIMUS; WARFARIN;

ARTICLE; BLEEDING; CASE REPORT; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; FULMINATING PURPURA; GENE MUTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; PARTIAL THROMBOPLASTIN TIME; PROTEIN C DEFICIENCY; PROTHROMBIN TIME; RETINA HEMORRHAGE; SKIN GRAFT; SKIN NECROSIS; SURVIVAL TIME; THROMBOSIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; FEMALE; GENES, RECESSIVE; HOMOZYGOTE; HUMANS; INFANT; LIVER TRANSPLANTATION; PROTEIN C; PROTEIN C DEFICIENCY; PURPURA FULMINANS; RECURRENCE; THROMBOSIS; TREATMENT OUTCOME;

EID: 59449110175     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00972.x     Document Type: Article

References (15)

1. Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982 : 59 : 1067 1072.
2. Marlar RA, Montgomery RR, Broekmans AW, The Working Party. Diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and Haemostasis. J Pediatr 1989 : 114 : 528 534.
3. Hartman KR, Manco-Johnson M, Rawlings JS, Bower DJ, Marlar RA. Homozygous protein C deficiency: Early treatment with warfarin. Am J Pediatr Hematol Oncol 1989 : 11 : 395 401.
4. Hubbard AR. Standardization of protein C in plasma: Establishment of an international standard. Thromb Haemost 1988 : 59 : 464 467.
5. Schwarz HP, Schramm W, Dreyfus M. Monoclonal antibody purified protein C concentrate: Intitial clinical experience. In : Bruley DF, Drohan WN, eds. Protein C and Related Anticoagulants. Houston : Gulf Publishing, 1990 : pp. 83 89.
6. Dreyfus M, Magny JF, Bridey F, et al. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991 : 325 : 1565 1568.
7. Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983 : 2 : 1165 1168.
8. Minford AM, Parapia LA, Stainforth C, Lee D. Treatment of homozygous protein C deficiency with subcutaneous protein C concentrate. Br J Haematol 1996 : 93 : 215 216.
9. Sanz-Rodriguez C, Gil-Fernandez JJ, Zapater P, et al. Long-term management of homozygous protein C deficiency: Replacement therapy with subcutaneous purified protein C concentrate. Thromb Haemost 1999 : 81 : 887 890.
10. Hwang S, Lee SG, Lee YJ, et al. Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe. Liver Transpl 2006 : 12 : 920 927.
11. Casella JF, Lewis JH, Bontempo FA, Zitelli BJ, Markel H, Starzl TE. Successful treatment of homozygous protein C deficiency by hepatic transplantation. Lancet 1988 : 1 : 435 437.
12. Angelis M, Pegelow CH, Khan FA, Verzaro R, Tzakis AG. En bloc heterotopic auxiliary liver and bilateral renal transplant in a patient with homozygous protein C deficiency. J Pediatr 2001 : 138 : 120 122.
13. Chenard-Neu MP, Boudjema K, Bernuau J, et al. Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure - a multicenter European study. Hepatology 1996 : 23 : 1119 1127.
14. Fridell JA, Jain A, Reyes J, et al. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Transplantation 2002 : 74 : 1721 1724.
15. Corman SL, Coley KC, Schonder KS. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients. Pharmacotherapy 2006 : 26 : 1433 1437.